134 related articles for article (PubMed ID: 27754925)
1. The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study.
Mozessohn L; Earle C; Spaner D; Cheng SY; Kumar M; Buckstein R
J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754925
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
Nam GE; Kim SM; Han K; Kim NH; Chung HS; Kim JW; Han B; Cho SJ; Yu JH; Park YG; Choi KM
PLoS Med; 2018 Aug; 15(8):e1002640. PubMed ID: 30130376
[TBL] [Abstract][Full Text] [Related]
3. Components of metabolic syndrome and prognosis of renal cell cancer.
Eskelinen TJ; Kotsar A; Tammela TLJ; Murtola TJ
Scand J Urol; 2017 Dec; 51(6):435-441. PubMed ID: 28743221
[TBL] [Abstract][Full Text] [Related]
4. Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma.
Kubica AW; Rose PS; Weaver AL; Brewer JD
Mayo Clin Proc; 2011 Aug; 86(8):738-43. PubMed ID: 21803956
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada.
Blanc-Lapierre A; Spence A; Karakiewicz PI; Aprikian A; Saad F; Parent MÉ
BMC Public Health; 2015 Sep; 15():913. PubMed ID: 26385727
[TBL] [Abstract][Full Text] [Related]
6. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
[TBL] [Abstract][Full Text] [Related]
8. Association between metabolic syndrome and kidney cancer risk: a prospective cohort study.
Wang L; Du H; Sheng C; Dai H; Chen K
Lipids Health Dis; 2024 May; 23(1):142. PubMed ID: 38760801
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of older adults with chronic lymphocytic leukemia: A Surveillance, Epidemiology, and End Results-Medicare cohort study.
Duchesneau ED; McNeill AM; Schary W; Pate V; Lund JL
J Geriatr Oncol; 2023 Nov; 14(8):101602. PubMed ID: 37696241
[TBL] [Abstract][Full Text] [Related]
10. Metabolic consequences of snoring in adolescents and younger adults: a population study in Chile.
Brockmann PE; Damiani F; Smith DL; Castet A; Nuñez F; Villarroel L; Gozal D
Int J Obes (Lond); 2016 Oct; 40(10):1510-1514. PubMed ID: 27478923
[TBL] [Abstract][Full Text] [Related]
11. Low urine pH affects the development of metabolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study.
Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
PLoS One; 2018; 13(8):e0202757. PubMed ID: 30142166
[TBL] [Abstract][Full Text] [Related]
12. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
13. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.
Parikh SA; Leis JF; Chaffee KG; Call TG; Hanson CA; Ding W; Chanan-Khan AA; Bowen D; Conte M; Schwager S; Slager SL; Van Dyke DL; Jelinek DF; Kay NE; Shanafelt TD
Cancer; 2015 Sep; 121(17):2883-91. PubMed ID: 25931291
[TBL] [Abstract][Full Text] [Related]
14. Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.
Gao R; Man TS; Liang JH; Wang L; Zhu HY; Wu W; Fan L; Li JY; Yang T; Xu W
Cancer Res Treat; 2020 Jan; 52(1):189-206. PubMed ID: 31291713
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Health Status and Metabolic Syndrome in Adults Living in a Transition European Country: Findings from a Population-Based Study.
Stojisavljević D; Janković J; Erić M; Marinković J; Janković S
J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):568-574. PubMed ID: 29097061
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome definitions and components in predicting major adverse cardiovascular events after kidney transplantation.
Prasad GV; Huang M; Silver SA; Al-Lawati AI; Rapi L; Nash MM; Zaltzman JS
Transpl Int; 2015 Jan; 28(1):79-88. PubMed ID: 25207680
[TBL] [Abstract][Full Text] [Related]
18. Trace proteinuria by dipstick screening is associated with metabolic syndrome, hypertension, and diabetes.
Okada R; Yasuda Y; Tsushita K; Wakai K; Hamajima N; Matsuo S
Clin Exp Nephrol; 2018 Dec; 22(6):1387-1394. PubMed ID: 29934666
[TBL] [Abstract][Full Text] [Related]
19. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
Fingeret M; Marques-Vidal P; Vollenweider P
Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
[TBL] [Abstract][Full Text] [Related]
20. The metabolic syndrome and its components as prognostic factors in metastatic colorectal cancer.
Reed M; Patrick C; Croft B; Walde N; Voutsadakis IA
Indian J Gastroenterol; 2019 Feb; 38(1):15-22. PubMed ID: 30701442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
